AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionHartland & Co., LLC
Latest Disclosed Ownership134,159 shares
Latest Disclosed Value $ 29,178,209
Hartland & Co., LLC reports 31.84% increase in ownership of ABBV / AbbVie Inc.

On May 6, 2026 - Hartland & Co., LLC filed a 13F-HR form disclosing ownership of 134,159 shares of AbbVie Inc. (MX:ABBV) valued at $29,178,209 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 101,762 shares of AbbVie Inc.. This represents a change in shares of 31.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 134,159 32,397 31.84 29,178 25.49 0.2665
2026-02-09 2025-12-31 13F ABBVIE COM 00287Y109 101,762 343 0.34 23,251 -0.98 0.2931
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 101,419 -1,043 -1.02 23,483 23.47 0.3082
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 102,462 2,779 2.79 19,019 -8.94 0.2672
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 99,683 -390 -0.39 20,885 17.45 0.3240
2025-02-10 2024-12-31 13F ABBVIE COM 00287Y109 100,073 -384 -0.38 17,783 -10.36 0.2698
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 100,457 2,001 2.03 19,838 17.47 0.3078
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 98,456 44,861 83.70 16,887 95.38 0.2881
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 53,595 -636 -1.17 8,644 2.84 0.4279
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 54,231 850 1.59 8,404 5.63 0.4460
2023-11-13 2023-09-30 13F/A-1 ABBVIE COM 00287Y109 53,381 771 1.47 7,957 12.25 0.4888
2023-11-07 2023-09-30 13F ABBVIE COM 00287Y109 68,928 16,318 10,274 0.5651
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 52,610 6,017 12.91 7,088 -4.54 0.4296
2023-05-09 2023-03-31 13F ABBVIE COM 00287Y109 46,593 911 1.99 7,425 0.58 0.5405
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 45,682 -2,013 -4.22 7,383 15.33 0.5783
2022-11-15 2022-09-30 13F ABBVIE COM 00287Y109 47,695 -13,655 -22.26 6,401 -31.88 0.5897
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 61,350 422 0.69 9,396 -4.87 0.7323
2022-05-04 2022-03-31 13F ABBVIE COM 00287Y109 60,928 746 1.24 9,877 21.21 0.6701
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 60,182 2,451 4.25 8,149 30.87 0.5542
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 57,731 3,469 6.39 6,227 1.88 0.4645
2021-08-12 2021-06-30 13F ABBVIE COM 00287Y109 54,262 577 1.07 6,112 5.20 0.4704
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 53,685 5,517 11.45 5,810 12.58 0.4841
2021-02-11 2020-12-31 13F ABBVIE COM 00287Y109 48,168 9,890 25.84 5,161 53.92 0.4693
2020-11-12 2020-09-30 13F ABBVIE COM 00287Y109 38,278 771 2.06 3,353 -8.94 0.3594
2020-08-11 2020-06-30 13F ABBVIE COM 00287Y109 37,507 10,834 40.62 3,682 81.20 0.4258
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 26,673 -2,097 -7.29 2,032 -20.22 0.2959
2020-02-11 2019-12-31 13F ABBVIE COM 00287Y109 28,770 -180 -0.62 2,547 16.20 0.3091
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 28,950 -3,009 -9.42 2,192 -5.68 0.2933
2019-08-08 2019-06-30 13F ABBVIE COM 00287Y109 31,959 577 1.84 2,324 -8.11 0.3095
2019-05-14 2019-03-31 13F ABBVIE COM 00287Y109 31,382 -4,703 -13.03 2,529 -23.99 0.3488
2019-02-08 2018-12-31 13F ABBVIE COM 00287Y109 36,085 -909 -2.46 3,327 -4.92 0.5182
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 36,994 425 1.16 3,499 3.28 0.4798
2018-08-07 2018-06-30 13F ABBVIE COM 00287Y109 36,569 1,321 3.75 3,388 1.56 0.4832
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 35,248 -1,575 -4.28 3,336 -6.32 0.4834
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 36,823 -4,113 -10.05 3,561 -2.12 0.4827
2017-11-09 2017-09-30 13F ABBVIE COM 00287Y109 40,936 -302 -0.73 3,638 21.67 0.4738
2017-08-03 2017-06-30 13F ABBVIE COM 00287Y109 41,238 5,092 14.09 2,990 26.96 0.4367
2017-05-11 2017-03-31 13F ABBVIE COM 00287Y109 36,146 3,268 9.94 2,355 14.38 0.3422
2017-02-10 2016-12-31 13F ABBVIE COM 00287Y109 32,878 32,878 2,059 0.3332
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.